Chris Vazquez - 03 Jul 2023 Form 3 Insider Report for BIODESIX INC (BDSX)

Role
Chief Accounting Officer
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez
Issuer symbol
BDSX
Transactions as of
03 Jul 2023
Net transactions value
$0
Form type
3
Filing time
06 Jul 2023, 16:31:19 UTC
Next filing
26 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BDSX Common Stock 4,390 03 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BDSX Stock Options (Right to buy) 03 Jul 2023 Common Stock 16,000 $20.67 Direct F1
holding BDSX Stock Options (Right to buy) 03 Jul 2023 Common Stock 11,734 $2.29 Direct F2
holding BDSX Stock Options (Right to buy) 03 Jul 2023 Common Stock 52,034 $2.00 Direct F2
holding BDSX Restricted Stock Units 03 Jul 2023 Common Stock 6,619 Direct F3, F4
holding BDSX Restricted Stock Units 03 Jul 2023 Common Stock 814 Direct F3, F5
holding BDSX Restricted Stock Units 03 Jul 2023 Common Stock 18,776 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested 40% on February 23, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from February 23, 2023.
F2 This option is fully vested.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4 Represents RSUs remaining from an initial grant of 9,627 RSUs that vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F5 Represents RSUs remaining from an initial grant of 4,885 RSUs that vest in a series of six successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
F6 These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney